MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with G

Galantamine

Galantamine 4mg tablets

No stability information

Stability notes for Galantamine 4mg tablets

There are no stability notes for this medicine.

Supplier

Galantamine 4mg tablets (Special Order)

Galantamine 8mg modified-release capsules

Use with caution

Stability notes for Galantamine 8mg modified-release capsules

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 8mg capsules (Krka UK Ltd) and Reminyl XL 8mg capsules (Takeda UK Ltd).

Suppliers (9) of Galantamine 8mg modified-release capsules
Gaalin 8mg modified-release capsules (Milpharm Ltd)
Galantamine 8mg modified-release capsules (Alliance Healthcare (Distribution) Ltd)
Galantamine 8mg modified-release capsules (Imported)
Galantamine 8mg modified-release capsules (Krka UK Ltd)
Gatalin XL 8mg capsules (Aspire Pharma Ltd)
Gazylan XL 8mg capsules (Teva UK Ltd)
Lotprosin XL 8mg capsules (Accord-UK Ltd)
Luventa XL 8mg capsules (Fontus Health Ltd)
Reminyl XL 8mg capsules (Sigma Pharmaceuticals Plc)

Galantamine 16mg modified-release capsules

Use with caution

Stability notes for Galantamine 16mg modified-release capsules

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 16mg capsules (Krka UK Ltd) and Reminyl XL 16mg capsules (Takeda UK Ltd).

Suppliers (10) of Galantamine 16mg modified-release capsules
Gaalin 16mg modified-release capsules (Milpharm Ltd)
Galantamine 16mg modified-release capsules (Alliance Healthcare (Distribution) Ltd)
Galantamine 16mg modified-release capsules (Imported)
Galantamine 16mg modified-release capsules (Krka UK Ltd)
Gatalin XL 16mg capsules (Aspire Pharma Ltd)
Gazylan XL 16mg capsules (Teva UK Ltd)
Lotprosin XL 16mg capsules (Accord-UK Ltd)
Luventa XL 16mg capsules (Fontus Health Ltd)
Reminyl XL 16mg capsules (Abacus Medicine Ltd)
Reminyl XL 16mg capsules (Sigma Pharmaceuticals Plc)

Galantamine 24mg modified-release capsules

Use with caution

Stability notes for Galantamine 24mg modified-release capsules

Store in airtight containers. Protect from light and moisture.

Provenance

This compatibility recommendation is derived from Galsya XL 24mg capsules (Krka UK Ltd) and Reminyl XL 24mg capsules (Takeda UK Ltd).

Suppliers (10) of Galantamine 24mg modified-release capsules
Gaalin 24mg modified-release capsules (Milpharm Ltd)
Galantamine 24mg modified-release capsules (Alliance Healthcare (Distribution) Ltd)
Galantamine 24mg modified-release capsules (Imported)
Galantamine 24mg modified-release capsules (Krka UK Ltd)
Gatalin XL 24mg capsules (Aspire Pharma Ltd)
Gazylan XL 24mg capsules (Teva UK Ltd)
Lotprosin XL 24mg capsules (Accord-UK Ltd)
Luventa XL 24mg capsules (Fontus Health Ltd)
Reminyl XL 24mg capsules (Abacus Medicine Ltd)
Reminyl XL 24mg capsules (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.